Aims and Scope of Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University. Less
Key Metrics
CiteScore 

8.5
Eigenfactor 

0.005 - 0.01
Impact Factor 

5 - 10
SJR 

Q1Drug Discovery

SNIP 

1.17
Recommended pre-submission checks
Powered by 

Topics Covered on Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Drug Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Expert Opinion on Drug Discovery
In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives
- 3 Jun 2026
- Expert Opinion on Drug Discovery
The root cause: why do so many drugs fail to translate from bench to bedside?
- 3 Jun 2026
- Expert Opinion on Drug Discovery
The design of multi-target ligands and their role in schizophrenia therapy: an update
- 9 May 2026
- Expert Opinion on Drug Discovery
The application of fluorinated α-amino acids to drug discovery techniques
- 8 May 2026
- Expert Opinion on Drug Discovery
Multi-target approaches to prion disease drug discovery: a status update
- 7 May 2026
- Expert Opinion on Drug Discovery
Combining cutting edge computational and experimental methods for targeting kras mutations in non-small cell lung cancer
- 4 May 2026
- Expert Opinion on Drug Discovery
In vitro prediction of the immunogenicity of therapeutic proteins: state of the art and current challenges and perspectives
- 3 Jun 2026
- Expert Opinion on Drug Discovery
The root cause: why do so many drugs fail to translate from bench to bedside?
- 3 Jun 2026
- Expert Opinion on Drug Discovery
The design of multi-target ligands and their role in schizophrenia therapy: an update
- 9 May 2026
- Expert Opinion on Drug Discovery
The application of fluorinated α-amino acids to drug discovery techniques
- 8 May 2026
- Expert Opinion on Drug Discovery
Multi-target approaches to prion disease drug discovery: a status update
- 7 May 2026
- Expert Opinion on Drug Discovery
Combining cutting edge computational and experimental methods for targeting kras mutations in non-small cell lung cancer
- 4 May 2026
- Expert Opinion on Drug Discovery